Christof Vulsteke unpaid guest prof.

Publications Christof Vulsteke

Exploratory subgroup analyses of EV-302 : a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma

Source
ESMO Open - ISSN 2059-7029-10:8 (2025) p. 1-9
Author(s)
    M.S. van der Heijden, T. Powles, S. Gupta, Y. Loriot, M.D. Galsky, B.P. Valderrama, S.S. Sridhar, E.Y. Yu, G. Iyer, E. Kikuchi, D. Castellano, J. Hoffman-Censits, A. Drakaki, N. Mar, J.P. Maroto Rey, Christof Vulsteke, W. Arafat, I. Duran, N.A. Dawson, U. Swami, S. Gorla, B.H. Moreno, X. Yu, Y.-T. Lu, J. Bedke

Delayed FLAIR-enhancement of benign notochordal remnant (ecchordosis physaliphora)

Source
The Neuroradiology Journal - ISSN 1971-4009-38:2 (2025) p. 220-223
Author(s)
    Jeroen Peels, Christof Vulsteke, Michael Boedts, Eline Marin, Laurens J.L. De Cocker

The unjustified fear of erdafitinib-induced central serous retinopathy

Source
Annals of oncology - ISSN 0923-7534-36:8 (2025) p. 1001-1002
Author(s)

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?

Source
Acta oncologica - ISSN 0284-186X-64 (2025) p. 979-988
Author(s)
    Alexander Decruyenaere, Christine Gennigens, Sylvie Rottey, Annouschka Laenen, Emmanuel Seront, Els Everaert, Philip R. Debruyne, Heidi van den Bulck, Julie Bastin, Annelies Verbiest, Christof Vulsteke, Peter Schatteman, Daisy Luyten, Sandrine Aspeslagh, Nieves Martinez-Chanza, Marlies De Bock, Thomas Meyskens, Jolanda Verheezen, Barbara Brouwers, Benoit Beuselinck

Sacituzumab govitecan in advanced urothelial carcinoma : TROPiCS-04, a phase III randomized trial

Source
Annals of oncology - ISSN 0923-7534-36:5 (2025) p. 561-571
Author(s)
    T. Powles, S. Tagawa, Christof Vulsteke, M. Gross-Goupil, S.H. Park, A. Necchi, M. De Santis, I. Duran, R. Morales-Barrera, J. Guo, C.N. Sternberg, J. Bellmunt, P.J. Goebell, M. Kovalenko, F. Boateng, M. Sierecki, L. Wang, C.S. Sima, J. Waldes, Y. Loriot, P. Grivas